Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies-Reference-Cited by-同舟云学术

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Published:2018-03-01 Issue:9 Volume:23 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Rondy Marc¹²,Kissling Esther¹²,Emborg Hanne-Dorthe³,Gherasim Alin⁴,Pebody Richard⁵,Trebbien Ramona⁶,Pozo Francisco⁷,Larrauri Amparo⁴,McMenamin Jim⁸,Valenciano Marta²,

Affiliation:

1. MR and EK contributed equally to the study and manuscript writing

2. EpiConcept, Paris, France

3. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

4. National Epidemiology Centre, Institute of Health Carlos III, Madrid Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid Spain

5. Public Health England, London, United Kingdom

6. Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark

7. Inmaculada Casas National Centre for Microbiology, National Influenza Reference Laboratory, World Health Organization National Influenza Centre, Institute of Health Carlos III

8. Health Protection Scotland, Glasgow, United Kingdom

Abstract

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, −42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference31 articles.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and evolution of hemagglutinin and neuraminidase genes of Influenza A(H3N2) viruses in Thailand during 2015 to 2018;PeerJ;2024-06-03

2. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines;Human Vaccines & Immunotherapeutics;2024-04-15

3. Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent;2024-02-06

4. Optimal timing of influenza vaccination among patients with acute myocardial infarction – Findings from the IAMI trial;Vaccine;2023-11

5. Symptomatic Differences between Influenza A/H3N2 and A/H1N1 in Korea;Journal of Clinical Medicine;2023-08-30